Neurocognitive Assessment in Youth Initiating HAART
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
ATN 071 is a prospective cohort study comparing neurocognitive functioning in four groups of
youth, age 18-24: Two groups with CD4+ T cells above 350 cells/mm3 and HIV RNA >1,000
copies/ml, one initiating HAART (Group 1) and the other not initiating treatment (Group 2);
and two groups with CD4+ T cells < 350 cells/mm3, one initiating treatment (Group 3) and the
other not initiating treatment (Group 4). Groups 2 and 3 represent standard of care. Group 1
and a portion of group 2 will be co-enrolled in ATN 061 and will be randomly assigned to
group by that protocol.
Details
Lead Sponsor:
University of North Carolina, Chapel Hill Westat
Collaborators:
National Institute of Mental Health (NIMH) National Institute on Drug Abuse (NIDA)